KNCV welcomes Worldwide Access Plan for Delamanid

In Bangkok on Wednesday, 24 February, Lucica Diutu, Chair of the Stop TB Partnership, and Rajesh Gupta, Senior Director at the Otsuka, jointly announced the launch of a Worldwide Access Plan for delamanid with the Stop TB Partnership’s Global Drug Facility (GDF). Delamanid, developed and manufactured by Otsuka, is one of the two new drugs approved to treat multidrug-resistant tuberculosis (MDR-TB). This new drug will be available to over 100 countries through the GDF for a price of US$ 1700 per patient. KNCV welcomes the availability of delamanid through this mechanism, which means that patients will have better treatment options than before.

Currently only 50% of MDR-TB patients can be treated successfully. The access to delamanid means an important step in improvement of MDR-TB patients’ treatment options, for the first time now also including children, for whom the company has brought a dispersible tablet on the market.

KNCV Tuberculosis Foundation is supporting countries to provide access to and utilization of delamanid, as well as to bedaquiline: the other new drug for MDR-TB treatment, available through GDF since April 2015.

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.